MeVis Medical Solutions AG (M3V.DE)
EUR 24.6
(0.0%)
EUR 24.6
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 17.34 Million EUR | -7.57% |
| 2022 | 18.76 Million EUR | 15.71% |
| 2021 | 16.21 Million EUR | -5.35% |
| 2020 | 17.13 Million EUR | -5.21% |
| 2019 | 18.07 Million EUR | 7.85% |
| 2018 | 16.75 Million EUR | -9.61% |
| 2017 | 18.54 Million EUR | 15.0% |
| 2016 | 16.12 Million EUR | 0.67% |
| 2015 | 16.01 Million EUR | 22.33% |
| 2014 | 13.09 Million EUR | -10.44% |
| 2013 | 14.61 Million EUR | 9.52% |
| 2012 | 13.34 Million EUR | -2.42% |
| 2011 | 13.67 Million EUR | -4.29% |
| 2010 | 14.29 Million EUR | 3.04% |
| 2009 | 13.86 Million EUR | 27.9% |
| 2008 | 10.84 Million EUR | 37.4% |
| 2007 | 7.89 Million EUR | -5.39% |
| 2006 | 8.34 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.38 Million EUR | 0.0% |
| 2024 Q1 | 4.38 Million EUR | -1.07% |
| 2023 Q1 | 4.23 Million EUR | -17.06% |
| 2023 FY | 17.34 Million EUR | -7.57% |
| 2023 Q4 | 4.43 Million EUR | 0.0% |
| 2023 Q3 | 4.43 Million EUR | 4.69% |
| 2023 Q2 | 4.23 Million EUR | 0.0% |
| 2022 Q3 | 5.1 Million EUR | -40.23% |
| 2022 FY | 18.76 Million EUR | 15.71% |
| 2022 Q4 | 5.1 Million EUR | 0.0% |
| 2022 Q1 | 4.27 Million EUR | -47.47% |
| 2022 Q2 | 8.54 Million EUR | 100.0% |
| 2021 Q1 | 4.04 Million EUR | -52.21% |
| 2021 FY | 16.21 Million EUR | -5.35% |
| 2021 Q4 | 8.13 Million EUR | 100.0% |
| 2021 Q3 | 4.06 Million EUR | -49.67% |
| 2021 Q2 | 8.08 Million EUR | 100.0% |
| 2020 FY | 17.13 Million EUR | -5.21% |
| 2020 Q1 | 4.33 Million EUR | -20.82% |
| 2020 Q2 | 8.67 Million EUR | 100.0% |
| 2020 Q3 | 4.22 Million EUR | -51.29% |
| 2020 Q4 | 8.45 Million EUR | 100.0% |
| 2019 Q4 | 5.47 Million EUR | 25.95% |
| 2019 FY | 18.07 Million EUR | 7.85% |
| 2019 Q3 | 4.35 Million EUR | 7.86% |
| 2019 Q2 | 4.03 Million EUR | -4.23% |
| 2019 Q1 | 4.21 Million EUR | -8.95% |
| 2018 Q3 | 3.9 Million EUR | -1.27% |
| 2018 Q2 | 3.95 Million EUR | -7.77% |
| 2018 Q1 | 4.28 Million EUR | -1.4% |
| 2018 FY | 16.75 Million EUR | -9.61% |
| 2018 Q4 | 4.62 Million EUR | 18.59% |
| 2017 Q1 | 5.53 Million EUR | 25.27% |
| 2017 Q3 | 4.44 Million EUR | 5.24% |
| 2017 Q4 | 4.34 Million EUR | -2.16% |
| 2017 Q2 | 4.21 Million EUR | -23.8% |
| 2017 FY | 18.54 Million EUR | 15.0% |
| 2016 Q4 | 4.42 Million EUR | 16.47% |
| 2016 Q1 | 4.08 Million EUR | -14.89% |
| 2016 FY | 16.12 Million EUR | 0.67% |
| 2016 Q3 | 3.79 Million EUR | -2.09% |
| 2016 Q2 | 3.87 Million EUR | -5.02% |
| 2015 FY | 16.01 Million EUR | 22.33% |
| 2015 Q4 | 4.79 Million EUR | 28.55% |
| 2015 Q3 | 3.73 Million EUR | 9.45% |
| 2015 Q2 | 3.4 Million EUR | -0.64% |
| 2015 Q1 | 3.43 Million EUR | -4.7% |
| 2014 Q4 | 3.59 Million EUR | 11.29% |
| 2014 Q3 | 3.23 Million EUR | 14.36% |
| 2014 Q2 | 2.82 Million EUR | -20.23% |
| 2014 Q1 | 3.54 Million EUR | -15.8% |
| 2014 FY | 13.09 Million EUR | -10.44% |
| 2013 Q2 | 3.31 Million EUR | 2.6% |
| 2013 Q1 | 3.23 Million EUR | -0.03% |
| 2013 FY | 14.61 Million EUR | 9.52% |
| 2013 Q3 | 3.54 Million EUR | 6.81% |
| 2013 Q4 | 4.21 Million EUR | 18.79% |
| 2012 Q3 | 3.24 Million EUR | -10.64% |
| 2012 Q4 | 3.23 Million EUR | -0.19% |
| 2012 Q2 | 3.62 Million EUR | 1.4% |
| 2012 FY | 13.34 Million EUR | -2.42% |
| 2012 Q1 | 3.57 Million EUR | 4.81% |
| 2011 Q3 | 2.97 Million EUR | -20.12% |
| 2011 Q1 | 3.38 Million EUR | -5.42% |
| 2011 FY | 13.67 Million EUR | -4.29% |
| 2011 Q2 | 3.71 Million EUR | 9.74% |
| 2011 Q4 | 3.41 Million EUR | 14.92% |
| 2010 Q1 | 3.6 Million EUR | -7.81% |
| 2010 Q2 | 3.71 Million EUR | 3.28% |
| 2010 Q3 | 3.6 Million EUR | -3.09% |
| 2010 FY | 14.29 Million EUR | 3.04% |
| 2010 Q4 | 3.58 Million EUR | -0.58% |
| 2009 Q4 | 3.9 Million EUR | 34.47% |
| 2009 Q2 | 3.46 Million EUR | 0.0% |
| 2009 FY | 13.86 Million EUR | 27.9% |
| 2009 Q3 | 2.9 Million EUR | -16.07% |
| 2008 Q3 | 3.04 Million EUR | 0.0% |
| 2008 FY | 10.84 Million EUR | 37.4% |
| 2007 FY | 7.89 Million EUR | -5.39% |
| 2006 FY | 8.34 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| DocCheck AG | 53.41 Million EUR | 67.533% |
| CompuGroup Medical SE & Co. KGaA | 1.18 Billion EUR | 98.54% |
| Nexus AG | 241.45 Million EUR | 92.818% |